Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Tutt

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Radiology|March 25, 2014
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapyJyoti Parikh, Mariyah Selmi, Geoff Charles-Edwards, et al.
Molecular Cancer Research : MCR|October 5, 2010
GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activationAurélie Cazet, Jonathan Lefebvre, Eric Adriaenssens, et al.
Breast Cancer (Tokyo, Japan)|May 12, 2023
Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trialHideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
Breast Cancer Research : BCR|February 19, 2008
Are triple-negative tumours and basal-like breast cancer synonymous?Emad A Rakha, David S P Tan, William D Foulkes, et al.
Scientific Reports|January 7, 2017
Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survivalFilipe Gracio, Brian Burford, Patrycja Gazinska, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Cancer Research|July 2, 2014
IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancersPierfrancesco Marra, Sumi Mathew, Anita Grigoriadis, et al.
Science Translational Medicine|October 11, 2019
An innate-like Vδ1<sup>+</sup> γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancerYin Wu, Fernanda Kyle-Cezar, Richard T Woolf, et al.
Cellular Signalling|May 19, 2024
PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cellsAikaterini Pipili, Nouf A Babteen, Lujain Kuwair, et al.
The Journal of Pathology. Clinical Research|February 9, 2018
Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancersAnita Grigoriadis, Patrycja Gazinska, Trupti Pai, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Radiology|March 25, 2014
Changes in primary breast cancer heterogeneity may augment midtreatment MR imaging assessment of response to neoadjuvant chemotherapyJyoti Parikh, Mariyah Selmi, Geoff Charles-Edwards, et al.
Molecular Cancer Research : MCR|October 5, 2010
GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activationAurélie Cazet, Jonathan Lefebvre, Eric Adriaenssens, et al.
Breast Cancer (Tokyo, Japan)|May 12, 2023
Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trialHideko Yamauchi, Masakazu Toi, Shin Takayama, et al.
Breast Cancer Research : BCR|February 19, 2008
Are triple-negative tumours and basal-like breast cancer synonymous?Emad A Rakha, David S P Tan, William D Foulkes, et al.
Scientific Reports|January 7, 2017
Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survivalFilipe Gracio, Brian Burford, Patrycja Gazinska, et al.
Breast Cancer Research : BCR|November 1, 2013
An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic riskChristina Yau, John Sninsky, Shirley Kwok, et al.
Cancer Research|July 2, 2014
IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancersPierfrancesco Marra, Sumi Mathew, Anita Grigoriadis, et al.
Science Translational Medicine|October 11, 2019
An innate-like Vδ1<sup>+</sup> γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancerYin Wu, Fernanda Kyle-Cezar, Richard T Woolf, et al.
Cellular Signalling|May 19, 2024
PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cellsAikaterini Pipili, Nouf A Babteen, Lujain Kuwair, et al.
The Journal of Pathology. Clinical Research|February 9, 2018
Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node-positive breast cancersAnita Grigoriadis, Patrycja Gazinska, Trupti Pai, et al.
Pageof 10